Ad-PSMA vaccine (VectorLogics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAd-PSMA vaccine (VectorLogics)
Drug Alias Nameadenoviral prostate specific membrane antigen vaccine (VectorLogics)dendritic cell-targeted vaccine (VectorLogics)dual CD40 costimulator/PSMA antigen (adenoviral vector vaccine) (VectorLogics)prostate cancer vaccine (VectorLogics)adenoviral PSMA vaccine (VectorLogics)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsTumor necrosis factor receptor superfamily member 5 agonists
TargetsTumor necrosis factor receptor superfamily member 5Prostate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVectorlogics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVectorlogics
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A